Showing results (201-210 of 696) with videos related to
Sort By:
Pageof 70
Therapeutic Advances in Endocrinology and Metabolism|June 11, 2020
Epicardial adipose tissue: an emerging biomarker of cardiovascular complications in type 2 diabetes?Regitse Højgaard Christensen, Bernt Johan von Scholten, Louise Lang Lehrskov, et al.Journal of Clinical & Translational Endocrinology|December 18, 2019
The effect of needle tenotomy on hammer, mallet and claw toe deformities in patients with diabetes, a retrospective studyJonas Hedegaard Andersen, Anne Rasmussen, Marie Frimodt-Møller, et al.Diabetes Care|January 31, 2006
Cardiac autonomic neuropathy predicts cardiovascular morbidity and mortality in type 1 diabetic patients with diabetic nephropathyAnne Sofie Astrup, Lise Tarnow, Peter Rossing, et al.Journal of Diabetes and Its Complications|August 14, 2012
Serum amyloid A and C-reactive protein levels may predict microalbuminuria and macroalbuminuria in newly diagnosed type 1 diabetic patientsAnne Julie Overgaard, James N McGuire, Peter Hovind, et al.Journal of Diabetes and Its Complications|April 14, 2024
Gastrointestinal symptom burden in diabetic autonomic and peripheral neuropathy - A Danes cohort studyHuda Kufaishi, Hatice Isik Mizrak, Birgitte Brock, et al.Kidney International|August 18, 2005
Improved prognosis in type 1 diabetic patients with nephropathy: a prospective follow-up studyAnne Sofie Astrup, Lise Tarnow, Peter Rossing, et al.Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|June 30, 2009
Autoregulation of glomerular filtration rate during spironolactone treatment in hypertensive patients with type 1 diabetes: a randomized crossover trialKatrine J Schjoedt, Per K Christensen, Anders Jorsal, et al.Diabetes Care|September 5, 2020
Improved Time in Range Over 1 Year Is Associated With Reduced Albuminuria in Individuals With Sensor-Augmented Insulin Pump-Treated Type 1 DiabetesAjenthen G Ranjan, Signe V Rosenlund, Tine W Hansen, et al.Diabetes, Obesity & Metabolism|February 10, 2025
Efficacy and hypoglycaemia outcomes with once-weekly insulin icodec versus once-daily basal insulin in individuals with type 2 diabetes by kidney function: A post hoc participant-level analysis of the ONWARDS 1-5 trialsPeter Rossing, Malik Benamar, Alice Y Y Cheng, et al.Diabetes, Obesity & Metabolism|June 30, 2021
A large remaining potential in lipid-lowering drug treatment in the type 2 diabetes population: A Danish nationwide cohort studyHanan Amadid, Pernille F Rønn, Maria Bekker-Nielsen Dunbar, et al.Pageof 70